NCT00176592View on ClinicalTrials.gov

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Multiple Sclerosis
Interventions
DRUG

Betaseron

Betaseron 250 micrograms injected SQ every other day

DRUG

Copaxone

Copaxone 20 mg injected SQ every day (glatiramer acetate)

Trial Locations (1)

07103

New Jersey Medical School, Newark

All Listed Sponsors
lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00176592 - Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI | Biotech Hunter | Biotech Hunter